Kana mashoko ekuti "kenza yepancreatic" akaonekwa pamushumo wekuongorora chirwere—kunyanya kana achiperekedzwa ne "25 liver metastases"—mhuri dzisingaverengeki dzakawira mukuora mwoyo. Chirwere ichi, chinozivikanwa se "mambo wekenza," chakamboonekwa chine multiple metastases, chinowanzoreva nguva yekupona inoyerwa mu "mwedzi" kana kunyange "mavhiki." Asi nhasi, tinoda kugovera nyaya yechokwadi kubva kuBeijing South Region Oncology Hospital—nezvemurwere wekenza wekuShandong, China, akawanazve tariro pano, akararama nehupenyu hwepamusoro kwemakore anopfuura maviri, uye achiri kuenderera mberi nerwendo rwake rwehupenyu.
Murwere wekupedzisira akambopiwa "mwedzi mitanhatu" ava kurarama murunyararo kwemakore maviri.
Makore maviri apfuura, apo murwere uyu akasvika kuchipatara kekutanga, mamiriro ake ezvinhu akanga akaipa zvikuru: akaonekwa aine kenza yepancreas, aine maronda makumi maviri nemashanu akapararira muchiropa chake, uye chiyero cheCA199 chebundu chakakwira kusvika 32,680 U/mL (huwandu hwakajairika hunowanzova pasi pe37 U/mL). Sekureva kwetsika, kenza yepancreas yekupedzisira ine metastases yechiropa yakawanda ine mwero wakaderera wekurarama kwemwedzi mitanhatu, uye nzira dzekurapa dzakaganhurirwa muChina nekune dzimwe nyika.
Zvisinei, chikwata chenyanzvi kuBeijing South Region Oncology Hospital International Department hachina kurega. Panzvimbo pekushandisa nzira dzekurapa dzinoshandiswa nevanhu vakawanda dzinowanzokonzera kukuvara kukuru kuvarwere vari muchikamu chekupedzisira—“kurasikirwa nevanhu vedu chiuru kuti tiuraye mazana masere evavengi”—vakaunza tekinoroji yepamusoro, yegirini, isingashandisi vanhu vakawanda: High-Intensity Focused Ultrasound (HIFU).
- Kurapa kumwe chete, kubvisa maronda makumi maviri nematanhatu: Muna Gumiguru 2023, vanachiremba vakabvisa bundu rekutanga mumusoro wepancreas uye ma metastases ese makumi maviri nemashanu echiropa panguva imwe chete. Maitiro ese aive asina kuchekwa, asina ropa, uye aisada kuisirwa nhubhu.
- Kushanda kwakajairika kwakatangazve zuva rakatevera kurapwa: Kurapa kwacho hakuna kukanganisa zvakanyanya immune system yemurwere, zvichidzivirira matambudziko anowanzoitika muvarwere vari padanho rekupedzisira akadai sehutachiona mushure mekuvhiyiwa uye kutadza kupora kwemaronda.
- Mhedzisiro yemakore maviri inoshamisa: Ongororo dzekutevera dzichangoburwa dzinoratidza kuti CA199 yake yaderera kusvika pa5.66—yakajairika chose. PET-CT yakasimbisa kuti bundu rekutanga uye metastases yese yechiropa hairatidzi chirwere chinoshanda mumasero, zvichireva kuti maronda acho "akamiswa kushanda" zvinobudirira, uye chirwere ichi chakaramba chakasimba kwenguva refu.
Nhasi uno, murwere uyu haana kungorarama kwemakore anopfuura maviri chete asiwo ane hupenyu hwakanaka. Anototaurawo nezverwendo rwake rwekurwisa kenza paDouyin (TikTok).
Sei HIFU ichivhura mukana mutsva kune varwere vegomarara vari padanho rekupedzisira?
Kune varwere vegomarara vari padanho rekupedzisira vasina kudya kwakakwana uye vane masoja emuviri asina simba, kuvhiyiwa kwechivanhu, radiotherapy, uye chemotherapy zvinowanzo kundikana. Zvakanakira zveHIFU zviri mu:
- Hazvipindi uye zvakasvibira: Mafungu e ultrasound anotarisa kubva kunze kwemuviri anobvisa maronda ari mukati, asingasiyi maronda paganda.
- Hapana kukuvara kwenyama yakajairwa: Kuderedza kukanganiswa kwesimba remuviri rekudzivirira muviri, zvichichengetedza simba rekurapa kwakabatana kunotevera.
- Inokwanisa kurapa kupararira kwemasero akawanda mumuviri panguva imwe chete: Chero bedzi paine nzira yakachengeteka ye ultrasound, inogona "kumisa" mamota akapararira muchiropa nekune dzimwe nzvimbo.
- Inoderedza mutoro wegomarara nekukurumidza: Kutenga nguva nenzvimbo inokosha yekupora kwemasoja emuviri.
Sezvakataurwa naProfessor Li Lijun, Mutungamiriri weHIFU Center paBeijing South Region Oncology Hospital, pavakaongorora nyaya iyi:
> "Kuwanda kwezvirwere zvechiropa hazvichari chinhu chinopesana neHIFU. Nyaya iyi inotiudza kuti: kunonoka kwechirwere hazvirevi kuti chirwere chinopera. Kurapwa kwakakodzera kwemunzvimbo kunogona kunyora patsva curve yekurarama kwemurwere. Sevanachiremba, chatinonyanya kutarisira kuona hachisi 'kuisa zvinyorwa,' asi varwere vanorarama kwenguva refu uye vane hupenyu hwakanaka."
Yakavhurika Kune Varwere Vepasi Pose: Masuo Edu Akavhurika Zvakakura
Dhipatimendi reInternational kuBeijing South Region Oncology Hospital rakatsaurira kupa nzira dzekurapa dzepamusoro, dzetsitsi, uye dzakagadzirirwa varwere vegomarara pasi rese. Kunyangwe iwe kana mudiwa wako ari kutarisana negomarara repancreas, gomarara rechiropa, sarcoma yemapfupa akapfava, uterine fibroids, kana mamwe mabundu akaomarara, tekinoroji yedu yeHIFU uye nzira yekurapa ine hunyanzvi hwakawanda inogona kukuunzira shanduko isingatarisirwi.
Tibatanei Nhasi Kuti Muwane Pfungwa Dzechipiri kana Kuongororwa Kwekurapwa
Tinopa mabasa emitauro miviri muchiChinese neChirungu, tichibatsira varwere vekune dzimwe nyika nekukurukura vari kure, tsamba dzekukoka vhiza, kuronga kupinda muchipatara, uye kutarisirwa kwekutevera.
Kubvunzana Nefoni
��� 400-880-3716
��� Nhamba yeWeChat: 17801183037
��� Email 1: 100085_010@163.com
��� Email 2: myimmnet@163.com
Tariro yako inogona kunge iri kure nekutaurirana kamwe chete.
Tinonzwisisa kuti kutsvaga rubatsiro rwechiremba mhiri kwemiganhu kunoda ushingi hukuru nekuvimbana. Asi yeukai: murwere uya wekuShandong akamira pamharadzano imwe chete makore maviri apfuura. Akasarudza Beijing South Region Oncology Hospital, akasarudza HIFU, uye nhasi achiri kurarama hupenyu hwakajairika, achiri kukurudzira vamwe varwere paDouyin, achiri kuratidza nenyaya yake kuti kunyange "mambo wekenza" haakundiki.
Usamirira kusvika mangwana.
Mukurapa kenza, nguva yakakosha. Hazvina mhosva kuti uri padanho ripi, kubvunzana kamwe chete, email imwe chete, kufona kamwe chete kunogona kuvhura mukana mutsva wehupenyu.
��� 400-880-3716
��� WeChat: 17801183037
��� 100085_010@163.com or myimmnet@163.com
Dhipatimendi rePasirose reChipatara cheOncology cheBeijing South Region
— Kuchengetedza hupenyu hwevarwere vegomarara pasi rese nehunyanzvi hwepamusoro, husingakuvadzi.
Nguva yekutumira: Kubvumbi-21-2026